Intelligent Bio Solutions (INBS) Debt to Equity (2021 - 2024)
Historic Debt to Equity for Intelligent Bio Solutions (INBS) over the last 4 years, with Q1 2024 value amounting to $0.01.
- Intelligent Bio Solutions' Debt to Equity fell 8270.7% to $0.01 in Q1 2024 from the same period last year, while for Mar 2024 it was $0.01, marking a year-over-year decrease of 8270.7%. This contributed to the annual value of $0.11 for FY2023, which is N/A changed from last year.
- Latest data reveals that Intelligent Bio Solutions reported Debt to Equity of $0.01 as of Q1 2024, which was down 8270.7% from $0.07 recorded in Q4 2023.
- Intelligent Bio Solutions' Debt to Equity's 5-year high stood at $0.23 during Q3 2023, with a 5-year trough of $0.0 in Q2 2021.
- Moreover, its 4-year median value for Debt to Equity was $0.05 (2022), whereas its average is $0.06.
- As far as peak fluctuations go, Intelligent Bio Solutions' Debt to Equity surged by 4242.18% in 2023, and later plummeted by 8270.7% in 2024.
- Intelligent Bio Solutions' Debt to Equity (Quarter) stood at $0.01 in 2021, then skyrocketed by 874.15% to $0.05 in 2022, then surged by 42.42% to $0.07 in 2023, then crashed by 80.81% to $0.01 in 2024.
- Its Debt to Equity stands at $0.01 for Q1 2024, versus $0.07 for Q4 2023 and $0.23 for Q3 2023.